Early hydroxychloroquine macular toxicity

Arthritis and Rheumatism

Volumn 44, Issue 8, 2001, Pages 1959-1961

  Warner, Ann E ^a  

^a 4330 Wornall ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYCHLOROQUINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COLOR VISION TEST; EYE TOXICITY; FEMALE; HIGH RISK PATIENT; HUMAN; KIDNEY FUNCTION; PATIENT MONITORING; PATIENT SELECTION; PRIORITY JOURNAL; RETINA MACULOPATHY; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; VISUAL ACUITY; VISUAL FIELD;

ADULT; FEMALE; HUMANS; HYDROXYCHLOROQUINE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MACULAR DEGENERATION;

EID: 0034885827     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200108)44:8<1959::AID-ART334>3.0.CO;2-A     Document Type: Article

References (30)

1. Incidence of hydroxychloroquine retinopathy in 1,207 patients in a large multicenter outpatient practice
2. Hydroxychloroquine, dosage parameters and retinopathy
3. Continuation of long term treatment with hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis
4. Ocular safety of hydroxychloroquine
5. Hydroxychloroquine retinopathy
6. Retinopathy after long term, standard doses of hydroxychloroquine
7. Retinal toxicity in long term hydroxychloroquine treatment
8. Ophthalmological monitoring for hydroxychloroquine toxicity: A scientific review of the available data
9. Chloroquine: Ophthalmological safety, and clinical assessment in rheumatoid arthritis
10. Ocular lesions in rheumatoid arthritis and related disorders with particular reference to retinopathy
11. Ring maculopathies mimicking chloroquine retinopathy
12. Current practices for monitoring ocular toxicity related to hydroxychloroquine (Plaquenil) therapy
13. Detection and prevention of maculopathy associated with antimalarial agents
14. Screening for hydroxychloroquine retinal toxicity: Is it necessary?
15. Hydroxychloroquine retinopathy: Is screening necessary?
16. Hydroxychloroquine and retinal safety
17. Screening for hydroxychloroquine retinopathy
18. Antimalarial ocular toxicity: A critical appraisal
19. Ophthalmologic considerations and testing in patients receiving long-term antimalarial therapy
20. Chloroquine retinopathy: A report of eight cases with ERG and dark adaptation findings
21. Delayed onset of chloroquine retinopathy
22. Ophthalmologic safety of long-term hydroxychloroquine sulfate treatment
23. Validity and interpretation of Amsler grid reports
24. Retinopathy following chloroquine therapy
25. Comparison of hydroxychloroquine and chloroquine use and the development of retinal toxicity
26. Ocular changes induced by long-term hydroxychloroquine (Plaquenil) therapy
27. Chloroquine (Aralen)-induced retinal damage
28. Chloroquine retinopathy with recovery in early stages
29. Hydroxychloroquine: Seven-year experience
30. A randomized study of the effects of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus